Term
|
Definition
| antiplatelet/analgesic/anti-inflammaory; nonselective COX1/COX2 inhibitor. |
|
|
Term
|
Definition
| antiplatelet; nonselective COX1/COX2 inhibitor |
|
|
Term
|
Definition
| antiplatelet/anti-inflammatory; selective COX2 inhibitor |
|
|
Term
|
Definition
| analgesic; COX3 inhibitor. Can cause liver tox |
|
|
Term
|
Definition
| antiplatelet; phosphodiesterase inhibitor → ↑ cAMP. Blocks adenosine reuptake |
|
|
Term
|
Definition
| antiplatelet; phosphodiesterase inhibitor → ↑ cAMP. Blocks adenosine reuptake |
|
|
Term
|
Definition
| antiplatelet; adenylate cyclase activator → ↑ cAMP |
|
|
Term
|
Definition
| antiplatelet; inhibits ADP activation of GPIIb/IIIa → inhibits aggregatory effect of platelets |
|
|
Term
|
Definition
| antiplatelet; synthetic peptide that blocks GPIIB/IIIA receptors |
|
|
Term
|
Definition
| antiplatelet; antibody that blocks GPIIB/IIIA receptors |
|
|
Term
|
Definition
| thrombolytic; forms active complex with plasminogen. Strongly immunogenic |
|
|
Term
|
Definition
| thrombolytic; directly cleaves plasminogen → plasmin |
|
|
Term
|
Definition
| thrombolytic; form a complex with plasminogen and fibrin that localizes it to the clot |
|
|
Term
|
Definition
| recombinant thrombolytic that works like tPA. |
|
|
Term
|
Definition
| antispasmodic; acts as GABA agonist at multiple levels in the spinal cord. |
|
|
Term
|
Definition
| antispasmodic; pre-synaptic α2 agonist to inhibit spinal cord motoneurons |
|
|
Term
|
Definition
| treats malignant hyperthermia and neuroleptic malignant syndrome; blocks ryanodine receptor sequestering Ca2+ in the sarcoplasmic reticulum. |
|
|
Term
|
Definition
| antispasmodic; works in RAS and spinal cord → sedation and altered perception of pain |
|
|
Term
|
Definition
| antispasmodic; generalized sedative actions in spinal cord and subcortical areas → inhibits multisynaptic reflexes |
|
|
Term
|
Definition
| antispasmodic and fibromyalgia tx; central action at the brainstem |
|
|
Term
|
Definition
| antispasmodic; generalized sedative action |
|
|
Term
|
Definition
| antispasmodic and tetanus tx; generalized sedative action |
|
|
Term
|
Definition
| antispasmodic and PD tx; generalized sedative action in the medulla and cerebral motor centers |
|
|
Term
|
Definition
| antispasmodic; central α2 agonist |
|
|
Term
|
Definition
| antispasmodic; prevents docking and release of Ach vesicles to interrupt nerve conduction |
|
|
Term
|
Definition
| fibromyalgia tx; GABA analogue that binds α2 subunit of Ca channel alleviating neuropathic pain, anxiety, and pain syndromes |
|
|
Term
|
Definition
| anticoagulant; binds ATIII to ↑ its activity |
|
|
Term
|
Definition
| LMWt heparin anticoagulant; binds ATIII to ↑ its activity |
|
|
Term
|
Definition
| LMWt heparin anticoagulant; binds ATIII to ↑ its activity |
|
|
Term
|
Definition
| LMWt heparin anticoagulant; binds ATIII to ↑ its activity |
|
|
Term
|
Definition
| LMWt heparin anticoagulant; binds ATIII to ↑ its activity |
|
|
Term
|
Definition
| LMWt heparin anticoagulant; binds ATIII to ↑ its activity |
|
|
Term
|
Definition
| LMWt heparin anticoagulant; binds ATIII to ↑ its activity |
|
|
Term
|
Definition
| LMWt heparin anticoagulant; binds ATIII to ↑ its activity |
|
|
Term
|
Definition
| anticoagulant; inactivates Xa |
|
|
Term
|
Definition
| anticoagulant; direct thrombin inhibitor. Independent action of ATIII. Smaller than ATIII so it can get into the clot and work there as well. |
|
|
Term
|
Definition
| anticoagulant; recombinant for of hirudin |
|
|
Term
| Bivalirudin/argatroban/melagatran/dabigatran |
|
Definition
| 2nd gen direct thrombin inhibitors; oral admin |
|
|
Term
|
Definition
| anticoagulant; competes with vit K epoxide to block carboxylation of II, VII, IX, X, protein C and S. |
|
|
Term
|
Definition
| anticoagulant; competes with vit K epoxide to block carboxylation of II, VII, IX, X, protein C and S. |
|
|
Term
|
Definition
| anticoagulant; competes with vit K epoxide to block carboxylation of II, VII, IX, X, protein C and S. |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| anti-diarrheal; coats the stomach |
|
|
Term
|
Definition
| anti-diarrheal; μ receptor agonist |
|
|
Term
|
Definition
| H1 antagonist/1st gen; treats allergies and colds |
|
|
Term
|
Definition
| H1 antagonist/1st gen; treats allergies and colds |
|
|
Term
|
Definition
| H1 antagonist/1st gen; treats allergies and colds |
|
|
Term
|
Definition
| H1 antagonist/2nd gen; treats allergies and colds |
|
|
Term
|
Definition
| H1 antagonist/1st gen; allergies and colds |
|
|
Term
|
Definition
| 2nd gen H1 antagonist; non-sedating for cold/hay fever |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| analgesic; μ receptor metabolized to morphine |
|
|
Term
|
Definition
| cough suppressant; non-narcotic |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| systemic and topical decongestant |
|
|
Term
|
Definition
|
|
Term
|
Definition
| systemic decongestant; precursor of methamphetamine |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| smoking cessation as part of CBT |
|
|
Term
|
Definition
| smoking cessation as part of CBT |
|
|
Term
| Nicotine Transdermal patch |
|
Definition
| smoking cessation as part of CBT |
|
|
Term
| What are some differences between unfractionated heparin and LMWT heparin? |
|
Definition
| LMWt hep has more specific stabilization of ATIII-Xa complex (less ATIII-thrombin). LMWt has less risk for HIT. LMWt has better regularity between molecules → more predictable. |
|
|
